Article

Allergan Foundation donates $2 million to UC-Irvine

The University of California-Irvine's department of ophthalmology received $2 million from the philanthropic arm of Allergan Inc., The Allergan Foundation. The donation will further strengthen the department's research agenda and clinical care. The gift was "the largest donation ever to ophthalmology," according to a joint press release from the university and Allergan.

The University of California-Irvine's department of ophthalmology received $2 million from the philanthropic arm of Allergan Inc., The Allergan Foundation. The donation will further strengthen the department's research agenda and clinical care. The gift was "the largest donation ever to ophthalmology," according to a joint press release from the university and Allergan.

In the future, UC-Irvine would like to develop a new facility called The Eye Institute. The facility would be dedicated to teaching, clinical care, and research on retinal diseases including diabetic retinopathy, macular degeneration, retinal degeneration, and retinitis pigmentosa. If the proposal is approved and funded, Allergan's contribution will be used to support retinal research within the institute and the department of ophthalmology.

"This generous and far-reaching gift from Allergan will have a lasting impact on the university, school of medicine, and the department of ophthalmology," said Chancellor Michael V. Drake. "The vital partnership we share with Allergan will further strengthen our position as an innovative center of excellence in ophthalmology that will improve lives in Orange County, the region, and beyond."

Some of the nation's top researchers in retinal disease, glaucoma, corneal disease, and refractive surgery work at UC-Irvine, and Allergan's donation will help them meet complex medical and surgical eye-care needs, conduct clinical research, develop programs and technologies in conjunction with industry, and seek clinical solutions to serious and debilitating eye-threatening diseases.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.